All Work

Chris Lange

Proteostasis Therapeutics Closes in on IPO

Proteostasis Therapeutics expects to price less than 4 million shares in the range of $12 to $14 apiece in an initial public offering valued up to around $62 million.

Chris Lange · 11 years ago

Major Oil Short Interest Backs Off

The January 29 short interest data have been compared with the previous figures, and short interest for the selected oil stocks is largely down.

Chris Lange · 11 years ago

Short Sellers Increase Bets in Major Pharma

The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.

Chris Lange · 11 years ago

Disney Earnings Appear to Not Be Enough for Investors

The Walt Disney Company (NYSE: DIS) reported fiscal first quarter financial results after the markets closed on Tuesday. The company had $1.63 in earnings per share (EPS) on $15.24 billion in revenue compared to…

Chris Lange · 11 years ago

What to Look for in Cisco Earnings

Cisco Systems is scheduled to report its fiscal second-quarter earnings after the markets close on Wednesday.

Chris Lange · 11 years ago

SEC Charges Manhattan Firm With Fraud

The SEC has announced fraud charges against American Growth Funding, a Manhattan-based lending company, and its owner is accused of repeatedly lying to investors purchasing high-yield securities.

Chris Lange · 11 years ago

What to Expect From Disney Earnings

Walt Disney is expected to report its fiscal first-quarter financial results after the markets close on Tuesday.

Chris Lange · 11 years ago

Regeneron Falls on Missed Earnings

Regeneron Pharmaceuticals reported disappointing fourth-quarter financial results before the markets opened on Tuesday.

Chris Lange · 11 years ago

How Analysts View GoPro After Q4 Earnings

After GoPro reported its fourth-quarter financial results after the markets closed on Wednesday, analysts began cutting their price targets.

Chris Lange · 11 years ago